SAKK 08/15 - PROMET - Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy

NCT02945813 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

112

Enrollment

OTHER

Sponsor class

Stopped Trial was prematurely closed for accrual by the SAKK Board and the follow-up period shortened to one year after last RT fraction of the last patient

Conditions

Prostate Cancer

Interventions

DRUG: Metformin
RADIATION: Salvage Radiotherapy SRT

Sponsor

Swiss Cancer Institute